Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Karyopharm Therapeutics (KPTI) Asset Utilization Ratio (2016 - 2025)

Karyopharm Therapeutics' Asset Utilization Ratio history spans 13 years, with the latest figure at 1.43 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 73.92% year-over-year to 1.43; the TTM value through Dec 2025 reached 1.43, up 73.92%, while the annual FY2025 figure was 1.07, 49.24% up from the prior year.
  • Asset Utilization Ratio reached 1.43 in Q4 2025 per KPTI's latest filing, up from 1.42 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.43 in Q4 2025 to a low of 0.36 in Q2 2021.
  • Average Asset Utilization Ratio over 5 years is 0.75, with a median of 0.72 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: surged 150.56% in 2022, then crashed 49.83% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.75 in 2021, then decreased by 28.95% to 0.53 in 2022, then rose by 7.36% to 0.57 in 2023, then soared by 43.44% to 0.82 in 2024, then soared by 73.92% to 1.43 in 2025.
  • Per Business Quant, the three most recent readings for KPTI's Asset Utilization Ratio are 1.43 (Q4 2025), 1.42 (Q3 2025), and 1.18 (Q2 2025).